Prostate cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients with pathologically confirmed low - and medium-risk prostate cancer (=18, urinary control function and defecation function basically normal; 2.Understand and voluntarily sign written informed consent.
Exclusion criteria
Exclusion criteria: 1.Patients with severe cardiopulmonary dysfunction or coagulation dysfunction that cannot be treated by surgery; 2.Patients with preoperative erectile dysfunction, urinary control and urination dysfunction; 3.Patients with pacemakers or other electrophysiological treatments; 4.Patients with previous history of abdominal and pelvic surgery or radiotherapy.Patients who underwent previous electroprostatectomy; 5.Patients with central and peripheral neuropathy; 6.Patients with severe anxiety, depression, mania or mental illness who are unable to cooperate with treatment and follow-up; 7.Patients with a history of other malignant tumors; 8.Patients with severe allergic constitution; 9.Patients who received prior endocrine therapy or radiotherapy for prostate cancer; 10.Patients whose physicians do not recommend neuromonitoring for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Corpus cavernosum electromyography;Intra cavernous pressure; | — |
Countries
China
Contacts
Chinese PLA General Hospital